Rare diseases
Investigational molecules
Locations
Back to Germany32 clinical trials in Bad Nauheim, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on hypertrophic cardiomyopathy treatments, including trials of mavacamten and aficamten. Research also covers advanced therapies for heart failure and pulmonary hypertension management.
Long-term safety and efficacy evaluations of novel cardiovascular medications are prioritized.
Advanced research in breast cancer treatment, particularly focusing on HER2-negative and triple-negative variants. Studies evaluate innovative combination therapies including atezolizumab and targeted treatments.
Emphasis on improving survival rates and reducing recurrence in early-stage breast cancer.
Clinical investigations of inflammatory diseases including myositis and arteritis. Studies evaluate new biological treatments and their long-term effectiveness in managing chronic inflammatory conditions.
Focus on developing targeted therapies for better disease control and improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
